NRP1 and breast carcinoma: Hence, targeting the TMD of NRP1, with a peptide mimicking its TMD could be a future potent drug in breast cancer therapy particularly to prevent metastasis formation by administrating long term low dose MTP-NRP1 upon reduction or surgical removal of the primary tumor.